Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

Oct 30 2018

• By Jessica Merrill

Ladder made of coins with colorful pills on top suggesting the growing prices of medicine or drugs

Related Content

Medicare's Foreign Price Bench-marking Will Only Hurt Bad Negotiators, HHS's Azar Argues

Oct 26 2018

HHS Advancing Attack On Rebates With Proposal To Revoke Safe Harbor

Jul 25 2018

Pfizer CEO Read Will Pass The Torch To Bourla In 2019

Oct 01 2018

Pfizer Agrees To Roll Back Prices On 40 Drugs, Yielding To Pressure From Trump

Jul 11 2018

Related Companies

Pfizer Inc.

Additional Topics

Pricing Debate Sales & Earnings Business Strategies Commercial BioPharmaceutical

More from Drug Pricing

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window